Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Factor One Source Pharmacy to buy Fast Access Specialty Therapeutics
Factor One Source Pharmacy (FOSRx) has agreed to acquire Fast Access Specialty Therapeutics (F.A.S.T.) for a combination of cash and stock.
Drug Discovery
-
03 Jan 2017
-
02 Jan 2017
TetraLogic sells SMAC Mimetic and HDAC Inhibitor assets to Medivir
TetraLogic Pharmaceuticals has completed the sale of its SMAC Mimetic and HDAC Inhibitor assets to Medivir.
-
07 Nov 2016
Onxeo unveils encouraging results from preclinical studies of Livatag in pancreatic cancer
Biopharmaceutical firm Onxeo has announced encouraging results from a series of preclinical studies evaluating Livatag interest for pancreatic cancer.